Tubersol Injection, Tuberculosis Testings, & TB Syringes
Trusted, FDA-Approved Tubersol Injection, TB Test Supplies & Syringes for Accurate Tuberculosis Screening and Hospital Infection Control
Tubersol injection is the gold-standard, FDA-approved purified protein derivative (PPD) for** tuberculosis (TB) testing** using the Mantoux technique. Trusted by hospitals, clinics, public health organizations, schools, pre-employment screening centers, and laboratories, Tubersol ensures reliable detection of latent and active TB infection in children, adults, healthcare workers, and high-risk populations. Combined with TB-specific syringes for precise, intradermal administration, Tubersol and related test supplies are essential for infection control, TB surveillance, and worldwide public health.
Purpose
- Tuberculosis (TB) Screening: Screen for latent TB infection (LTBI), active TB, and assess immunity status in at-risk or exposed individuals.
- Infection Control in Healthcare: Mandatory for employees, students, and patients in many healthcare and congregate environments.
- Public Health Surveillance: Key for travel, immigration, school, and workplace testing guidelines.
- Contact Tracing: Test close contacts of known TB-positive cases, ensuring early intervention.
Uses
- Routine TB Screening: Healthcare professionals, hospital staff, long-term care, correctional facilities, schools, shelters, pre-employment programs.
- Diagnostic Assessment: Investigation of known or suspected TB exposure, workup of unexplained cough or fever.
- Pre-Immigration & Travel Testing: For entry to countries or work settings with TB risk controls.
- Clinical Baseline or Surveillance: Immunocompromised patients (HIV, transplant), diabetes, or pre-biologic medications.
Types & Popular Brands
Types:
- Tubersol PPD Injection (Mantoux Test): 5 TU (tuberculin units) per 0.1 mL intradermal injection; supplied in multi-dose vials.
- TB Testing Syringes: Precision 1 mL syringes with 27g or 26g fine bevel needle for accurate intradermal placement.
- TB Skin Test Supplies: Alcohol prep pads, gloves, skin markers, ruler/caliper for induration measurement.
- Alternatives: Aplisol® (another purified protein derivative brand for TB testing); QuantiFERON® or T-SPOT®.TB (blood IGRA tests, not PPD).
Popular Brands:
- Tubersol® (Sanofi Pasteur): Gold-standard, FDA-approved PPD solution
- Aplisol® (Par Pharmaceuticals)
- BD (Becton Dickinson) TB Syringes (1 mL with permanently attached needle, slip tip or Luer-Lok)
- Monoject™ TB Syringes
- Terumo™, Nipro™ Single Use TB Syringes
- QuantiFERON®-TB Gold, T-SPOT®.TB (for laboratory-based TB blood tests)
Strengths
- Tubersol Injection: 5 TU/0.1 mL per test (standard single dose intradermally)
- Vial Sizes: 1 mL (10 test doses), 5 mL (50 test doses)
- TB Syringes: 1 mL precision with fine 27g–26g × 1/2”–5/8” intradermal needles
- Injection Volume: Always 0.1 mL per Mantoux test
Precautions
- Administer by Trained Professionals: Only for intradermal (not subcutaneous) use—improper technique may result in inaccurate results.
- Single-Person Needle/Syringe Use: NEVER reuse syringes or needles.
- Interpret with Caution: Requires 48–72 hour reading by a trained healthcare provider.
- False Positives: Can occur in people vaccinated with BCG or those with atypical mycobacteria.
- False Negatives: Immunosuppressed, malnourished, or very recent TB exposure may result in negative tests despite infection.
- Allergic Reactions: Hypersensitivity is rare, but any serious rash or swelling demands urgent attention.
- Confirmatory Testing: Positive results may require a chest X-ray or further IGRA blood tests.
- Avoid in Known Severe Allergic Reactions to PPD or Tuberculin Solution.
- Storage Requirements: Store Tubersol refrigerated (2°C–8°C); discard if solution is cloudy, contaminated, or expired.
- Documentation: Always record date, lot, and administration site for tracking and regulatory compliance.
Ensure accurate, reliable tuberculosis screening and infection control with FDA-approved Tubersol Injection, TB Testing Syringes, and complete TB test supplies—trusted by hospitals, clinics, schools, and workforces nationwide. Shop Tubersol®, BD TB syringes, Aplisol® and more for efficient, safe, and compliant Mantoux TB skin testing—order online for fast, sterile, and accurate TB screening every time!
- Primary focus: FDA-approved tuberculin injection products — Tubersol® (Sanofi Pasteur) and Aplisol® (Par Pharmaceuticals) — for Mantoux tuberculosis skin testing, supplied wholesale to licensed US healthcare providers.
- Standard dose: 5 tuberculin units (TU) per 0.1 mL administered intradermally; Tubersol® available in 1 mL (10-dose) and 5 mL (50-dose) vials.
- Complete supply scope: Tuberculin injection vials, precision TB syringes (BD, Monoject™, Terumo™, Nipro™), and supporting test supplies for end-to-end Mantoux testing compliance.
- Regulatory status: Tubersol® is FDA-approved under 21 CFR standards as stated in product labelling; all products are intended for use by licensed healthcare professionals only.
- Storage requirement: All PPD tuberculin injection vials must be refrigerated between 2°C and 8°C and protected from light; discard any cloudy, contaminated, or expired product immediately.
- Wholesale ordering: Free US shipping on orders over $100; 5% off first purchase for new accounts; bulk and institutional pricing available — contact sales for volume quotes.
- Tubersol® PPD Tuberculin Injection (Sanofi Pasteur): FDA-approved purified protein derivative for Mantoux TB skin testing; 5 TU per 0.1 mL intradermal; 1 mL (10 doses) and 5 mL (50 doses) multi-dose vials.
- Aplisol® PPD Tuberculin Injection (Par Pharmaceuticals): FDA-approved alternative TB solution; clinically equivalent to Tubersol® at 5 TU per 0.1 mL; appropriate substitute when formulary or supply requires an alternative injection tuberculin product.
- BD TB Syringes (Becton Dickinson): 1 mL precision syringes with permanently attached fine-bevel needles (27g–26g × ½"–5/8"); slip tip and Luer-Lok configurations; designed specifically for intradermal tuberculin injection delivery.
- Monoject™ TB Syringes: Single-use 1 mL intradermal syringes for TB injection administration; compatible with standard Mantoux technique protocol.
- Single-Use TB Syringes (Terumo™, Nipro™): Fine-gauge intradermal syringes for tuberculin shot delivery; single-patient use only in compliance with OSHA 29 CFR 1910.1030.
- TB Skin Test Supplies: Supporting materials for complete test administration, including alcohol prep pads, gloves, skin markers, and rulers or callipers for induration measurement at a 48–72-hour reading.
| Product | Type | Dose / Concentration | Available Sizes | Key Consideration |
|---|---|---|---|---|
| Tubersol® (Sanofi Pasteur) | PPD Tuberculin Injection | 5 TU / 0.1 mL intradermal | 1 mL (10 doses); 5 mL (50 doses) | FDA-approved under 21 CFR; preferred tb test injection in most US institutional formularies; refrigerate 2°C–8°C |
| Aplisol® (Par Pharmaceuticals) | PPD Tuberculin Injection | 5 TU / 0.1 mL intradermal | Not specified in the provided data | FDA-approved alternative injection tuberculin; clinically equivalent; suitable when Tubersol® is unavailable |
| BD TB Syringe (Becton Dickinson) | Intradermal Syringe | 0.1 mL delivery; 1 mL capacity | 27g–26g × ½"–5/8"; individual and bulk box | Permanently attached needle; slip tip or Luer-Lok; built for precise intradermal tb injection placement |
| Monoject™ TB Syringe | Intradermal Syringe | 0.1 mL delivery; 1 mL capacity | Fine-bevel needle; individual and bulk box | Single-use; compatible with Mantoux technique; meets OSHA 29 CFR 1910.1030 safe injection requirements |
| QuantiFERON®-TB Gold / T-SPOT®.TB | IGRA Blood Test (alternative method) | Laboratory blood draw | Not applicable | Preferred over TST for BCG-vaccinated individuals; not a tuberculin injection; not stocked in this collection |
- Healthcare worker screening: Baseline and annual tuberculin injection testing for hospital staff, nurses, physicians, and allied health professionals — required by CDC guidelines and institutional infection control programs.
- Pre-employment TB testing: Mandatory tuberculin shot screening for staff onboarding in schools, long-term care facilities, correctional institutions, shelters, and other congregate settings.
- Public health surveillance: TB skin test programs for community health initiatives, immigration processing, travel medicine, and government-mandated screening.
- Contact tracing: Administering injection tuberculin to close contacts of confirmed TB-positive cases to identify latent TB infection (LTBI) and support early clinical intervention.
- Clinical diagnostic workup: TB injection as part of investigation for unexplained pulmonary symptoms, known or suspected TB exposure, or pre-biologic therapy baseline immunological assessment.
- High-risk population screening: Immunocompromised patients (HIV, transplant recipients, those on immunosuppressive medications), individuals from high TB-prevalence regions, and residents of congregate living environments.
This product is intended for use by qualified healthcare professionals or under the guidance of a licensed medical provider. It is not a substitute for professional medical advice, diagnosis, or treatment.
- For standard Mantoux TB skin testing: Select Tubersol® PPD tuberculin injection (5 TU/0.1 mL); choose the 1 mL vial for low-volume clinic use or the 5 mL vial for high-throughput programs requiring up to 50 doses per vial.
- When Tubersol® supply is constrained: Aplisol® (Par Pharmaceuticals) is the FDA-approved equivalent tb solution at 5 TU per 0.1 mL — clinically interchangeable for Mantoux testing without protocol adjustment.
- For syringe selection: Use a 1 mL precision syringe with a 27-gauge or 26-gauge fine-bevel needle (½" to 5/8" length); BD and Monoject™ TB syringes are designed specifically for intradermal tuberculin injection delivery and are recommended for Mantoux compliance.
- For BCG-vaccinated or immunocompromised individuals: Consult current CDC TB testing guidelines to determine whether IGRA blood testing (QuantiFERON®-TB Gold or T-SPOT®.TB) is more appropriate — these tests are not included in this collection.
- For high-volume institutional programs: Order Tubersol® in 5 mL vials (50 doses) for cost efficiency; contact Mountainside Medical at +1 (888) 687-4334 for bulk institutional wholesale pricing on tb injection and syringe orders.
- Storage planning before ordering: Confirm refrigerated storage capacity (2°C–8°C) before placing bulk orders; do not order quantities that exceed your facility's ability to store and use within the product's labelled expiration period.
- Eligible purchasers only: Tubersol® and all prescription-classified tuberculin injection products are available exclusively to licensed healthcare professionals and verified institutional buyers; proof of medical licensure may be required at checkout or during account verification.
- Wholesale pricing: Competitive wholesale pricing across all TB testing supply categories; volume discounts apply to bulk orders — contact the Mountainside Medical sales team for institutional pricing quotes on tuberculin injection and TB syringe products.
- Free shipping threshold: Orders over $100 qualify for free US shipping; fast delivery supports time-sensitive restocking needs for TB screening programs.
- New account discount: New customers receive 5% off their first purchase; create an account to access wholesale pricing and manage order history.
- Bulk and institutional orders: Hospitals, public health departments, correctional facilities, and multi-site occupational health programs may contact the sales team directly at +1 (888) 687-4334 or sales@mountainside-medical.com for customised bulk order support.
- Cold-chain shipping: Tubersol® and PPD tuberculin injection products require refrigerated shipping; confirm delivery availability and timing before placing large orders to ensure cold-chain integrity upon receipt.
For Licensed Healthcare Professionals Only. Tubersol® injection, Aplisol®, and all tuberculin injection products in this collection are intended exclusively for purchase and use by licensed healthcare professionals, verified clinics, hospitals, public health agencies, and institutional buyers authorised under applicable US federal and state regulations. These products are not available for consumer purchase.
Not Medical Advice. All content on this page is provided for informational and procurement support purposes only. It does not constitute medical advice, clinical guidance, diagnosis, or treatment recommendations. All clinical decisions — including the selection, administration, and interpretation of tuberculin injection tests — remain the sole responsibility of the treating licensed healthcare provider.
Regulatory Compliance. Tubersol® is FDA-approved under 21 CFR standards as documented in its product labeling (Sanofi Pasteur). References to OSHA standards reflect OSHA 29 CFR 1910.1030 (Bloodborne Pathogens Standard). All regulatory compliance obligations related to TB testing remain the responsibility of the purchasing facility and its licensed clinical staff.
Result Interpretation. TB skin test results must be read and interpreted between 48 and 72 hours post-administration by a trained healthcare provider. A positive tuberculin shot result does not confirm active TB disease; confirmatory clinical evaluation, including chest X-ray and medical assessment, is required in accordance with current CDC TB testing guidelines.
Product Availability. Product availability, vial sizes, and pricing are subject to change without notice. Contact Mountainside Medical at +1 (888) 687-4334 or sales@mountainside-medical.com to confirm current stock and pricing prior to placing institutional or bulk orders.
-
What is a tuberculin injection and what is it used for?
A tuberculin injection is an intradermal administration of purified protein derivative (PPD) used to screen for tuberculosis (TB) infection using the Mantoux technique. The standard dose is 5 tuberculin units (TU) per 0.1 mL, injected intradermally into the forearm. It is used to detect latent TB infection (LTBI) and assess TB exposure status in healthcare workers, patients, students, pre-employment candidates, and high-risk populations. Tubersol® (Sanofi Pasteur) and Aplisol® (Par Pharmaceuticals) are the two FDA-approved PPD products used for this purpose in the United States under 21 CFR standards.
-
What is the tb test injection name used in US clinical practice?
The TB test injection used in US clinical practice is called the tuberculin skin test (TST), also known as the Mantoux test or PPD test. The most widely used product is Tubersol® (Sanofi Pasteur), an FDA-approved purified protein derivative solution. Aplisol® (Par Pharmaceuticals) is an equally FDA-approved alternative. Both are administered as a tuberculin injection of 0.1 mL intradermally and interpreted using the same CDC induration threshold criteria at 48–72 hours post-administration.
-
What is the difference between Tubersol® and Aplisol® as a tb solution?
Tubersol® (Sanofi Pasteur) and Aplisol® (Par Pharmaceuticals) are both FDA-approved purified protein derivative solutions for tuberculosis skin testing. Both deliver 5 TU per 0.1 mL intradermally and are clinically equivalent in efficacy for Mantoux testing, consistent with CDC TB testing guidance. The practical differences relate to manufacturer, vial size availability, and institutional formulary preference — not clinical performance. Tubersol® is available in 1 mL (10 doses) and 5 mL (50 doses) vials. When one product is unavailable due to supply constraints, the other is an appropriate substitute for continued TB screening compliance.
-
What syringe is used for a tb injection?
The Mantoux tuberculosis skin test requires a 1 mL precision syringe fitted with a fine-bevel 27-gauge or 26-gauge needle, ½ inch to 5/8 inch in length, designed for intradermal — not subcutaneous — injection. BD (Becton Dickinson) TB syringes with permanently attached needles in slip tip and Luer-Lok configurations, and Monoject™ TB syringes, are the principal products in this collection designed for this application. All TB syringes must be single-use only; reuse of needles or syringes is prohibited under OSHA 29 CFR 1910.1030 safe injection standards.
-
How long after a tuberculin shot are results read?
TB skin test results must be read between 48 and 72 hours after the tuberculin shot is administered. Results are evaluated by measuring the diameter of induration — the palpable raised area of skin — not surface redness. This reading must be performed by a trained healthcare provider. A result read outside this 48–72 hour window may not be considered clinically valid and the test may require repetition. CDC interpretation thresholds vary by patient risk category: 5 mm or greater for immunocompromised individuals, 10 mm or greater for high-risk groups, and 15 mm or greater for persons with no identified TB risk factors.
-
Can prior BCG vaccination affect the tuberculin injection result?
Yes. Prior BCG (Bacille Calmette-Guérin) vaccination can cause a false-positive tuberculin injection result because BCG uses a live attenuated mycobacterial strain that shares antigens with the PPD tb solution. This is a recognised limitation of the TST method. For BCG-vaccinated individuals, CDC guidelines recommend considering IGRA blood testing — such as QuantiFERON®-TB Gold or T-SPOT®.TB — as the preferred alternative, since IGRA tests are not affected by BCG vaccination status. IGRA tests are not included in this collection.
-
Who can legally purchase Tubersol® injection from Mountainside Medical?
Tubersol® injection and other prescription-classified tuberculin injection products are available exclusively to licensed healthcare professionals and verified institutional buyers. Eligible purchasers include physicians, nurse practitioners, physician assistants, licensed clinics, hospitals, public health agencies, EMS teams, occupational health programs, and correctional health facilities. These products are not available for direct consumer purchase. Proof of medical licensure may be required during account verification or at checkout. For institutional or bulk purchasing inquiries, contact Mountainside Medical at +1 (888) 687-4334 or sales@mountainside-medical.com.
-
What are the storage requirements for Tubersol® PPD tb solution?
Tubersol® PPD tb solution must be stored under refrigeration between 2°C and 8°C (36°F and 46°F) and protected from light at all times. The product must not be frozen. Any vial that appears cloudy, discoloured, or contains visible particulate matter must be discarded immediately, as must any vial that has exceeded its expiration date. These storage requirements are specified in the FDA product labeling for Tubersol® under 21 CFR standards. Facilities ordering Tubersol® for bulk TB screening programs should confirm adequate refrigerated storage capacity before placing large orders.
- Primary focus: FDA-approved tuberculin injection products — Tubersol® (Sanofi Pasteur) and Aplisol® (Par Pharmaceuticals) — for Mantoux tuberculosis skin testing, supplied wholesale to licensed US healthcare providers.
- Standard dose: 5 tuberculin units (TU) per 0.1 mL administered intradermally; Tubersol® available in 1 mL (10-dose) and 5 mL (50-dose) vials.
- Complete supply scope: Tuberculin injection vials, precision TB syringes (BD, Monoject™, Terumo™, Nipro™), and supporting test supplies for end-to-end Mantoux testing compliance.
- Regulatory status: Tubersol® is FDA-approved under 21 CFR standards as stated in product labelling; all products are intended for use by licensed healthcare professionals only.
- Storage requirement: All PPD tuberculin injection vials must be refrigerated between 2°C and 8°C and protected from light; discard any cloudy, contaminated, or expired product immediately.
- Wholesale ordering: Free US shipping on orders over $100; 5% off first purchase for new accounts; bulk and institutional pricing available — contact sales for volume quotes.
- Tubersol® PPD Tuberculin Injection (Sanofi Pasteur): FDA-approved purified protein derivative for Mantoux TB skin testing; 5 TU per 0.1 mL intradermal; 1 mL (10 doses) and 5 mL (50 doses) multi-dose vials.
- Aplisol® PPD Tuberculin Injection (Par Pharmaceuticals): FDA-approved alternative TB solution; clinically equivalent to Tubersol® at 5 TU per 0.1 mL; appropriate substitute when formulary or supply requires an alternative injection tuberculin product.
- BD TB Syringes (Becton Dickinson): 1 mL precision syringes with permanently attached fine-bevel needles (27g–26g × ½"–5/8"); slip tip and Luer-Lok configurations; designed specifically for intradermal tuberculin injection delivery.
- Monoject™ TB Syringes: Single-use 1 mL intradermal syringes for TB injection administration; compatible with standard Mantoux technique protocol.
- Single-Use TB Syringes (Terumo™, Nipro™): Fine-gauge intradermal syringes for tuberculin shot delivery; single-patient use only in compliance with OSHA 29 CFR 1910.1030.
- TB Skin Test Supplies: Supporting materials for complete test administration, including alcohol prep pads, gloves, skin markers, and rulers or callipers for induration measurement at a 48–72-hour reading.
| Product | Type | Dose / Concentration | Available Sizes | Key Consideration |
|---|---|---|---|---|
| Tubersol® (Sanofi Pasteur) | PPD Tuberculin Injection | 5 TU / 0.1 mL intradermal | 1 mL (10 doses); 5 mL (50 doses) | FDA-approved under 21 CFR; preferred tb test injection in most US institutional formularies; refrigerate 2°C–8°C |
| Aplisol® (Par Pharmaceuticals) | PPD Tuberculin Injection | 5 TU / 0.1 mL intradermal | Not specified in the provided data | FDA-approved alternative injection tuberculin; clinically equivalent; suitable when Tubersol® is unavailable |
| BD TB Syringe (Becton Dickinson) | Intradermal Syringe | 0.1 mL delivery; 1 mL capacity | 27g–26g × ½"–5/8"; individual and bulk box | Permanently attached needle; slip tip or Luer-Lok; built for precise intradermal tb injection placement |
| Monoject™ TB Syringe | Intradermal Syringe | 0.1 mL delivery; 1 mL capacity | Fine-bevel needle; individual and bulk box | Single-use; compatible with Mantoux technique; meets OSHA 29 CFR 1910.1030 safe injection requirements |
| QuantiFERON®-TB Gold / T-SPOT®.TB | IGRA Blood Test (alternative method) | Laboratory blood draw | Not applicable | Preferred over TST for BCG-vaccinated individuals; not a tuberculin injection; not stocked in this collection |
- Healthcare worker screening: Baseline and annual tuberculin injection testing for hospital staff, nurses, physicians, and allied health professionals — required by CDC guidelines and institutional infection control programs.
- Pre-employment TB testing: Mandatory tuberculin shot screening for staff onboarding in schools, long-term care facilities, correctional institutions, shelters, and other congregate settings.
- Public health surveillance: TB skin test programs for community health initiatives, immigration processing, travel medicine, and government-mandated screening.
- Contact tracing: Administering injection tuberculin to close contacts of confirmed TB-positive cases to identify latent TB infection (LTBI) and support early clinical intervention.
- Clinical diagnostic workup: TB injection as part of investigation for unexplained pulmonary symptoms, known or suspected TB exposure, or pre-biologic therapy baseline immunological assessment.
- High-risk population screening: Immunocompromised patients (HIV, transplant recipients, those on immunosuppressive medications), individuals from high TB-prevalence regions, and residents of congregate living environments.
This product is intended for use by qualified healthcare professionals or under the guidance of a licensed medical provider. It is not a substitute for professional medical advice, diagnosis, or treatment.
- For standard Mantoux TB skin testing: Select Tubersol® PPD tuberculin injection (5 TU/0.1 mL); choose the 1 mL vial for low-volume clinic use or the 5 mL vial for high-throughput programs requiring up to 50 doses per vial.
- When Tubersol® supply is constrained: Aplisol® (Par Pharmaceuticals) is the FDA-approved equivalent tb solution at 5 TU per 0.1 mL — clinically interchangeable for Mantoux testing without protocol adjustment.
- For syringe selection: Use a 1 mL precision syringe with a 27-gauge or 26-gauge fine-bevel needle (½" to 5/8" length); BD and Monoject™ TB syringes are designed specifically for intradermal tuberculin injection delivery and are recommended for Mantoux compliance.
- For BCG-vaccinated or immunocompromised individuals: Consult current CDC TB testing guidelines to determine whether IGRA blood testing (QuantiFERON®-TB Gold or T-SPOT®.TB) is more appropriate — these tests are not included in this collection.
- For high-volume institutional programs: Order Tubersol® in 5 mL vials (50 doses) for cost efficiency; contact Mountainside Medical at +1 (888) 687-4334 for bulk institutional wholesale pricing on tb injection and syringe orders.
- Storage planning before ordering: Confirm refrigerated storage capacity (2°C–8°C) before placing bulk orders; do not order quantities that exceed your facility's ability to store and use within the product's labelled expiration period.
- Eligible purchasers only: Tubersol® and all prescription-classified tuberculin injection products are available exclusively to licensed healthcare professionals and verified institutional buyers; proof of medical licensure may be required at checkout or during account verification.
- Wholesale pricing: Competitive wholesale pricing across all TB testing supply categories; volume discounts apply to bulk orders — contact the Mountainside Medical sales team for institutional pricing quotes on tuberculin injection and TB syringe products.
- Free shipping threshold: Orders over $100 qualify for free US shipping; fast delivery supports time-sensitive restocking needs for TB screening programs.
- New account discount: New customers receive 5% off their first purchase; create an account to access wholesale pricing and manage order history.
- Bulk and institutional orders: Hospitals, public health departments, correctional facilities, and multi-site occupational health programs may contact the sales team directly at +1 (888) 687-4334 or sales@mountainside-medical.com for customised bulk order support.
- Cold-chain shipping: Tubersol® and PPD tuberculin injection products require refrigerated shipping; confirm delivery availability and timing before placing large orders to ensure cold-chain integrity upon receipt.
For Licensed Healthcare Professionals Only. Tubersol® injection, Aplisol®, and all tuberculin injection products in this collection are intended exclusively for purchase and use by licensed healthcare professionals, verified clinics, hospitals, public health agencies, and institutional buyers authorised under applicable US federal and state regulations. These products are not available for consumer purchase.
Not Medical Advice. All content on this page is provided for informational and procurement support purposes only. It does not constitute medical advice, clinical guidance, diagnosis, or treatment recommendations. All clinical decisions — including the selection, administration, and interpretation of tuberculin injection tests — remain the sole responsibility of the treating licensed healthcare provider.
Regulatory Compliance. Tubersol® is FDA-approved under 21 CFR standards as documented in its product labeling (Sanofi Pasteur). References to OSHA standards reflect OSHA 29 CFR 1910.1030 (Bloodborne Pathogens Standard). All regulatory compliance obligations related to TB testing remain the responsibility of the purchasing facility and its licensed clinical staff.
Result Interpretation. TB skin test results must be read and interpreted between 48 and 72 hours post-administration by a trained healthcare provider. A positive tuberculin shot result does not confirm active TB disease; confirmatory clinical evaluation, including chest X-ray and medical assessment, is required in accordance with current CDC TB testing guidelines.
Product Availability. Product availability, vial sizes, and pricing are subject to change without notice. Contact Mountainside Medical at +1 (888) 687-4334 or sales@mountainside-medical.com to confirm current stock and pricing prior to placing institutional or bulk orders.
-
What is a tuberculin injection and what is it used for?
A tuberculin injection is an intradermal administration of purified protein derivative (PPD) used to screen for tuberculosis (TB) infection using the Mantoux technique. The standard dose is 5 tuberculin units (TU) per 0.1 mL, injected intradermally into the forearm. It is used to detect latent TB infection (LTBI) and assess TB exposure status in healthcare workers, patients, students, pre-employment candidates, and high-risk populations. Tubersol® (Sanofi Pasteur) and Aplisol® (Par Pharmaceuticals) are the two FDA-approved PPD products used for this purpose in the United States under 21 CFR standards.
-
What is the tb test injection name used in US clinical practice?
The TB test injection used in US clinical practice is called the tuberculin skin test (TST), also known as the Mantoux test or PPD test. The most widely used product is Tubersol® (Sanofi Pasteur), an FDA-approved purified protein derivative solution. Aplisol® (Par Pharmaceuticals) is an equally FDA-approved alternative. Both are administered as a tuberculin injection of 0.1 mL intradermally and interpreted using the same CDC induration threshold criteria at 48–72 hours post-administration.
-
What is the difference between Tubersol® and Aplisol® as a tb solution?
Tubersol® (Sanofi Pasteur) and Aplisol® (Par Pharmaceuticals) are both FDA-approved purified protein derivative solutions for tuberculosis skin testing. Both deliver 5 TU per 0.1 mL intradermally and are clinically equivalent in efficacy for Mantoux testing, consistent with CDC TB testing guidance. The practical differences relate to manufacturer, vial size availability, and institutional formulary preference — not clinical performance. Tubersol® is available in 1 mL (10 doses) and 5 mL (50 doses) vials. When one product is unavailable due to supply constraints, the other is an appropriate substitute for continued TB screening compliance.
-
What syringe is used for a tb injection?
The Mantoux tuberculosis skin test requires a 1 mL precision syringe fitted with a fine-bevel 27-gauge or 26-gauge needle, ½ inch to 5/8 inch in length, designed for intradermal — not subcutaneous — injection. BD (Becton Dickinson) TB syringes with permanently attached needles in slip tip and Luer-Lok configurations, and Monoject™ TB syringes, are the principal products in this collection designed for this application. All TB syringes must be single-use only; reuse of needles or syringes is prohibited under OSHA 29 CFR 1910.1030 safe injection standards.
-
How long after a tuberculin shot are results read?
TB skin test results must be read between 48 and 72 hours after the tuberculin shot is administered. Results are evaluated by measuring the diameter of induration — the palpable raised area of skin — not surface redness. This reading must be performed by a trained healthcare provider. A result read outside this 48–72 hour window may not be considered clinically valid and the test may require repetition. CDC interpretation thresholds vary by patient risk category: 5 mm or greater for immunocompromised individuals, 10 mm or greater for high-risk groups, and 15 mm or greater for persons with no identified TB risk factors.
-
Can prior BCG vaccination affect the tuberculin injection result?
Yes. Prior BCG (Bacille Calmette-Guérin) vaccination can cause a false-positive tuberculin injection result because BCG uses a live attenuated mycobacterial strain that shares antigens with the PPD tb solution. This is a recognised limitation of the TST method. For BCG-vaccinated individuals, CDC guidelines recommend considering IGRA blood testing — such as QuantiFERON®-TB Gold or T-SPOT®.TB — as the preferred alternative, since IGRA tests are not affected by BCG vaccination status. IGRA tests are not included in this collection.
-
Who can legally purchase Tubersol® injection from Mountainside Medical?
Tubersol® injection and other prescription-classified tuberculin injection products are available exclusively to licensed healthcare professionals and verified institutional buyers. Eligible purchasers include physicians, nurse practitioners, physician assistants, licensed clinics, hospitals, public health agencies, EMS teams, occupational health programs, and correctional health facilities. These products are not available for direct consumer purchase. Proof of medical licensure may be required during account verification or at checkout. For institutional or bulk purchasing inquiries, contact Mountainside Medical at +1 (888) 687-4334 or sales@mountainside-medical.com.
-
What are the storage requirements for Tubersol® PPD tb solution?
Tubersol® PPD tb solution must be stored under refrigeration between 2°C and 8°C (36°F and 46°F) and protected from light at all times. The product must not be frozen. Any vial that appears cloudy, discoloured, or contains visible particulate matter must be discarded immediately, as must any vial that has exceeded its expiration date. These storage requirements are specified in the FDA product labeling for Tubersol® under 21 CFR standards. Facilities ordering Tubersol® for bulk TB screening programs should confirm adequate refrigerated storage capacity before placing large orders.